More Company News

Scancell

Publication highlights potential of Modi-1
24 Jun 2020Read More

Scancell

Cancer Research publication highlights potential of AvidiMab
12 Jun 2020Read More

Scancell

Development of vaccine against COVID-19
24 Apr 2020Read More

Scancell

SCIB1 IND application approved
03 Feb 2020Read More

Scancell

H120 interim results
31 Jan 2020Read More

Scancell

Third agreement signed for antibody platform
20 Jan 2020Read More

Scancell

Second agreement signed for AvidiMab platform
16 Dec 2019Read More

Scancell

New European Moditope patent allowed for grant
20 Nov 2019Read More

Scancell

Six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
26 Sep 2019Read More

Scancell

First collaboration agreement for its new platform technology, AvidiMab
04 Sep 2019Read More

1 2 3 4
Return to Scancell
© 2019-20 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).